BRCA1: A scaffold for p53 response?

Trends in Genetics

Volumn 19, Issue 9, 2003, Pages 489-494

  Hohenstein, Peter ^a,b   Giles, Rachel H ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

DNA DAMAGE; GENE FUNCTION; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0041828227     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(03)00193-8     Document Type: Article

References (52)

1. Venkitaraman A.R. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 108:2002;171-182.
2. Wang Y., et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939.
3. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer. 2:2002;594-604.
4. Hakem R., et al. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell. 85:1996;1009-1023.
5. Hakem R., et al. Partial rescue of Brca1 (5-6) early embryonic lethality by p53 or p21 null mutation. Nat. Genet. 16:1997;298-302.
6. Crook T., et al. p53 mutations in BRCA1-associated familial breast cancer. Lancet. 350:1997;638-639.
7. Chai Y.L., et al. The second BRCT domain of BRCA1 proteins interacts with p53 and stimulates transcription from the p21WAF1/CIP1 promoter. Oncogene. 18:1999;263-268.
8. Zhang H., et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene. 16:1998;1713-1721.
9. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 268:2001;2764-2772.
10. Brooks C.L., Gu W. Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr. Opin. Cell Biol. 15:2003;164-171.
11. Cortez D., et al. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 286:1999;1162-1166.
12. Lee J.S., et al. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 404:2000;201-204.
13. Foray N., et al. A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein. EMBO J. 22:2003;2860-2871.
14. Swift M., et al. Incidence of cancer in 161 families affected by ataxia-telangiectasia. New Engl. J. Med. 325:1991;1831-1836.
15. Bell D.W., et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 286:1999;2528-2531.
16. *)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet. 31:2002;55-59.
17. Pao G.M., et al. CBP/p300 interact with and function as transcriptional coactivators of BRCA1. Proc. Natl. Acad. Sci. U. S. A. 97:2000;1020-1025.
18. Yarden R.I., Brody L.C. BRCA1 interacts with components of the histone deacetylase complex. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4983-4988.
19. Bochar D.A., et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell. 102:2000;257-265.
20. Lee D., et al. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J. Biol. Chem. 277:2002;22330-22337.
21. Klochendler-Yeivin A., et al. SWI/SNF chromatin remodeling and cancer. Curr. Opin. Genet. Dev. 12:2002;73-79.
22. Scully R., et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 90:1997;425-435.
23. Li S., et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature. 406:2000;210-215.
24. Wu-Baer F., Baer R. Effect of DNA damage on a BRCA1 complex. Nature. 414:2001;36.
25. Xu X., et al. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Nat. Genet. 28:2001;266-271.
26. Huber L.J., et al. Impaired DNA damage response in cells expressing an exon 11-deleted murine Brca1 variant that localizes to nuclear foci. Mol. Cell. Biol. 21:2001;4005-4015.
27. Moynahan M.E., et al. Brca1 controls homology-directed DNA repair. Mol. Cell. 4:1999;511-518.
28. Lim D.S., Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 16:1996;7133-7143.
29. Heyer B.S., et al. Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14:2000;2072-2084.
30. Futaki M., Liu J.M. Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol. Med. 7:2001;560-565.
31. Grossman S.R. p300/CBP/p53 interaction and regulation of the p53 response. Eur. J. Biochem. 268:2001;2773-2778.
32. Shikama N., et al. A novel cofactor for p300 that regulates the p53 response. Mol. Cell. 4:1999;365-376.
33. Avantaggiati M.L., et al. Recruitment of p300/CBP in p53-dependent signal pathways. Cell. 89:1997;1175-1184.
34. Luo J., et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 107:2001;137-148.
35. Prives C., Manley J.L. Why is p53 acetylated? Cell. 107:2001;815-818.
36. Barlev N.A., et al. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol. Cell. 8:2001;1243-1254.
37. Qian H., et al. Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites. Oncogene. 21:2002;7901-7911.
38. Inga A., et al. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell. Biol. 22:2002;8612-8625.
39. Flores E.R., et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature. 416:2002;560-564.
40. Costanzo A., et al. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes. Mol. Cell. 9:2002;175-186.
41. Anderson M.E., et al. Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation. Mol. Cell. Biol. 17:1997;6255-6264.
42. Espinosa J.M., Emerson B.M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol. Cell. 8:2001;57-69.
43. Fan S., et al. p300 modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 62:2002;141-151.
44. Otsuki T., et al. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet. 10:2001;2651-2660.
45. Samuels-Lev Y., et al. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell. 8:2001;781-794.
46. Masson J.Y., West S.C. The Rad51 and Dmc1 recombinases: a non-identical twin relationship. Trends Biochem. Sci. 26:2001;131-136.
47. Sonoda E., et al. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17:1998;598-608.
48. Scully R., et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 88:1997;265-275.
49. Saito S., et al. ATM mediates phosphorylation at multiple p53 sites, including Ser(46), in response to ionizing radiation. J. Biol. Chem. 277:2002;12491-12494.
50. Hofmann T.G., et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol. 4:2002;1-10.
51. Tibbetts R.S., et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2000;2989-3002.
52. Yarden R.I., et al. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat. Genet. 30:2002;285-289.